EN BLOC RESECTION OF RETINAL VASOPROLIFERATIVE TUMOR USING 23G VITRECTOMY. A CASE REPORT
Authors:
F. Forgáč 1,3; M. Sekerešová 2; M. Černák 3
Authors‘ workplace:
Očná klinika Fakultná nemocnica Nitra
1; Ústav patológie Fakultná nemocnica Nitra
2; Excimer – Očné laserové centrum, Školiace pracovisko Slovenskej, zdravotníckej univerzity v Bratislave v oblasti refrakčnej, (excimerovej) chirurgie
3
Published in:
Čes. a slov. Oftal., 78, 2022, No. 4, p. 206-213
Category:
Case Report
doi:
https://doi.org/10.31348/2022/22
Overview
Purpose: Retinal vasoproliferative tumor is one of the benign vascular tumors which in advanced stages leads to exudative retinal detachment with the formation of epiretinal and subretinal membranes. In such advanced stages, one of the therapeutic options is pars plana vitrectomy. This article presents the case of a patient on whom was performed 23-gauge pars plana phacovitrectomy with en bloc resection of the tumor followed by histological confirmation.
Case report: A 70-year-old patient with a one-year history of unilateral loss of vision in his left eye was admitted to our clinic for examination in February 2018. At admission, the best corrected visual acuity in the right eye was 1.0, and in the left eye was light perception. Based on the clinical picture, sonographic examination of the eye, and fluorescein angiography, the patient was diagnosed with a retinal vasoproliferative tumor. Due to the advanced stage of disease, we proceeded with surgical intervention. We performed 23-gauge phacovitrectomy with a bloc resection of the tumor. Subsequent histological examination confirmed the presence of the presumed tumor. The follow-up exam a few months later showed a completely attached retina with silicone oil tamponade, without exudative retinopathy. However, the best corrected visual acuity improved only slightly to the ability to count fingers at one meter.
Conclusion: Pars plana vitrectomy with en bloc resection of retinal vasoproliferative tumor is one of the therapeutic modalities in advanced stages.
Keywords:
retinal vasoproliferative tumor – pars plana vitrektomy – en bloc resection – exudative retinal detachment
Sources
1. Shields CL, Kaliki S, Al-Dahmash S et al. Retinal Vasoproliferative Tumors, Comparative Clinical Features of Primary vs Secondary Tumors in 334 Cases. JAMA Ophthalmol. 2013; 131(3):328-334.
2. Heimann H, Bornfeld N, Vij O et al. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000; 84(10):1162-1169.
3. Marback EF, Guerra RL, De Oliveira Maia OJ, Marback RL. Retinal vasoproliferative tumor. Arq Bras Oftalmol. 2013; 76(3):201-203.
4. Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995; 113(5):615-623.
5. Makdoumi K, Crafoord S. Vasoproliferative retinal tumours in a Swedish population. Acta Ophthalmol. 2011; 89(1):91-94.
6. Rennie IG. Retinal vasoproliferative tumours. Eye (Lond). 2010; 24(3):468-471.
7. Irvine F, O´Donnel N, Kemp E, Lee WR. Retinal Vasoproliferative Tumors, Surgical Management and Histlogical Findings. Arch Ophthalmol. 2000; 118(4):563-569.
8. Smith J, Steel D. The Surgical Management of Vasoproliferative Tumours. Ophthalmologica. 2011; 226(1):42-45.
9. Boixadera A, García-Arumí J, Martínez-Castillo V et al. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology. 2009; 116(5):100-105.
10. Blasi MA, Scupola A, Tiberti AC, Sasso P, Balestrazzi E. Photodynamic therapy for vasoproliferative retinal tumors. Retina. 2006; 26(4):404-409.
11. Anastassiou G, Bornfeld N, Schueler AO et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol. 2006; 90(4):447-450.
12. Cohen VM, Shields CL, Demirci H, Shields JA. Iodine I 125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol. 2008; 126(9):1245-1251.
13. Kenawy N, Groenwald C, Damato B. Treatment of a vasoproliferative tumour with ntravitreal bevacizumab (Avastin). Eye (Lond). 2007; 21(6):893-894.
14. Gibran SK. Trans-vitreal endoresection for vasoproliferative retinal tumours. Clinical & Experimental Ophthalmology. 2008; 36(8):712-716.
15. Yeh S, Wilson DJ. Pars Plana Vitrectomy and Endoresection of a Retinal Vasoproliferative Tumor. Arch Ophthalmol. 2010; 128(9):1196- 1199.
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2022 Issue 4
Most read in this issue
- VITAMIN D AND OPHTHALMOPATHIAS. A REVIEW
- EN BLOC RESECTION OF RETINAL VASOPROLIFERATIVE TUMOR USING 23G VITRECTOMY. A CASE REPORT
- COINCIDENCE OF IDIOPATHIC INTRACRANIAL HYPERTENSION AND LEBER HEREDITARY OPTIC NEUROPATHY. A CASE REPORT
- EFFECT OF RANIBIZUMAB AND AFLIBERCEPT ON RETINAL PIGMENT EPITHELIAL DETACHEMENT, SUBRETINAL AND INTRARETINAL FLUID IN AGE-RELATED MACULAR DEGENERATION